ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

IOBT IO Biotech Inc

1.48
-0.05 (-3.27%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
IO Biotech Inc IOBT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.05 -3.27% 1.48 06:30:01
개장가 저가 고가 종가 전일 종가
1.53 1.48 1.58 1.48 1.53
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202405:30GLOBEIO Biotech Announces Abstract Accepted for Presentation at..
15/04/202421:30GLOBEIO Biotech Expands Senior Leadership Team to Progress..
10/04/202401:00GLOBEIO Biotech Presents New Data at AACR 2024 Further Supporting..
05/04/202421:30GLOBEIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business..
12/03/202405:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/03/202406:11GLOBEIO Biotech Announces Acceptance of Abstract to be Presented..
06/03/202407:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/03/202406:46EDGAR2Form 8-K - Current report
06/03/202406:40GLOBEIO Biotech Announces 2023 Fourth-Quarter and Year-End..
27/02/202406:05GLOBEIO Biotech to Present at 44th Annual Cowen Health Care..
08/01/202422:11EDGAR2Form 8-K - Current report
21/12/202322:30GLOBEIO Biotech Announces First Patient Dosed in Phase 2..
25/11/202307:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:12GLOBEIO Biotech Announces 2023 Third Quarter Results
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:00GLOBEIO Biotech Appoints Helen Collins, MD, to its Board of..
10/11/202322:00GLOBEIO Biotech Completes Enrollment of 380 Patients in Pivotal..
09/11/202306:30GLOBEIO Biotech Announces Participation in Upcoming Investor..
01/11/202321:30GLOBEIO Biotech Presents Three Posters at the Society for..
23/10/202314:00GLOBEEncouraging Preliminary Data from a Phase 2 Trial Evaluating..
04/10/202305:30GLOBEIO Biotech Announces Three Poster Presentations at the..
13/09/202305:06EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
12/09/202321:05GLOBEIO Biotech Announces New Data Related to its IO102-IO103..
11/09/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
07/09/202323:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/09/202321:35GLOBEIO Biotech Announces Participation in Upcoming Investor..
31/08/202305:16EDGAR2Form S-3 - Registration statement under Securities Act of..
16/08/202307:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/08/202306:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/08/202310:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202321:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202321:31EDGAR2Form 8-K - Current report
11/08/202321:30GLOBEIO Biotech Announces 2023 Second Quarter Results
11/08/202321:05GLOBEIO Biotech Appoints Heidi Hunter to its Board of Directors
10/08/202309:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202309:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202321:05GLOBEIO Biotech Announces Abstract Accepted for Poster..
07/08/202321:31EDGAR2Form 8-K - Current report
07/08/202321:30GLOBEIO Biotech, Inc. Announces $75 Million Private Placement..
28/07/202321:05GLOBEIO Biotech Announces First Patient Dosed in..
26/07/202305:05GLOBEIO Biotech Announces Abstract Accepted for Mini Oral..
20/07/202305:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/07/202305:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/07/202305:05EDGAR2Form 8-K - Current report
19/07/202305:05GLOBEIO Biotech Strengthens Executive Management and US Presence..
14/06/202321:00GLOBEIO Biotech Announces Achievement of Significant Phase 3..
01/06/202321:30GLOBEIO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior..

최근 히스토리

Delayed Upgrade Clock